OBIO
Medtronic is acquiring Contego Medical for $380 million to expand its vascular portfolio.
Medtronic reports strong real-world safety and efficacy data for its cardiac ablation systems.
Medtronic wins TIME Best Inventions honors for two connected health technologies.
Medtronic fully divests MiniMed via oversubscribed share exchange, finalizing separation immediately.
Medtronic's oversubscribed MiniMed share exchange will fully divest its MiniMed stake.
Medtronic finalizes MiniMed exchange ratio; offer closes October 9, 2026.
Medtronic and Cornerstone Robotics announce a partnership with no disclosed financial terms.
Medtronic touts growth but provides no financial figures to back its claims.
Medtronic invests in Pi-Cardia but discloses no terms or financial details.
Medtronic confirms a $0.72 quarterly dividend, extending its 49-year increase streak.
Medtronic’s $650M deal is real, but the financial upside is distant and unproven.
Medtronic’s $550M deal is bold but long on hype, short on hard numbers.
Medtronic’s ICE investments are bold but lack financial detail and near-term payoff clarity.
Medtronic delivers solid growth, but some claims lack full supporting detail for investors.
Big promise, big price tag, but little hard data—wait for real numbers before acting.
Funding is real, but clinical and commercial payoffs are still years away and unproven.
This is a routine event update with no financial or strategic substance for investors.